Impact of Propofol-Based Total Intravenous Anesthesia Versus Anesthesia With Sevoflurane on Long-term Outcomes With Patients Undergoing Elective Excision of Primary Liver Tumors

• Status: Not yet recruiting
• Trial end date: 2027-03-31
• Target enrollment: 0
• Participant gender: All

Summary

This is a two-arm, parallel-group randomized clinical trial. Routine perioperative care would be performed in volunteers with primary Hepatocellular carcinoma. The study will enroll approximately 500 volunteers to compare the progression-free or overall survival in patients undergoing elective partial hepatectomy for primary liver tumors between propofol and sevoflurane for the maintenance of anesthesia.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
• Collaborator: Tri-Service General Hospital
• Treatments: Propofol; Sevoflurane

Criteria

Inclusion Criteria:

1. Twenty to eighty-year-old.

2. ASA class I-III.

3. Patients undergoing partial hepatectomy for hepatocellular carcinoma under general anesthesia.

Exclusion Criteria:

1. Severe mental disorder

2. Pregnant or lactating women

3. Morbidly obese

4. Allergy to any of the drugs used in this study

5. Recurrent tumor or repeat surgery

6. Biopsy cases

7. Incomplete data collection before the surgery

8. Palliative treatment after surgery

9. simultaneous treatment of other malignancies

10. Combined propofol and inhalation anesthesia or other anesthetics, such as ketamine or dexmedetomidine

11. Diagnosed as benign liver tumor

12. Emergency surgery